Rob Pieters Selected Research

Asparaginase (Elspar)

1/2022	Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working group.
11/2021	How much asparaginase is needed for optimal outcome in childhood acute lymphoblastic leukaemia? A systematic review.
1/2021	Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia.
1/2020	Individualized Asparaginase Dosing in Childhood Acute Lymphoblastic Leukemia.
12/2019	The effect of asparaginase therapy on methotrexate toxicity and efficacy in children with acute lymphoblastic leukemia.
11/2019	Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity.
1/2019	A cost-effectiveness analysis of Erwinia asparaginase therapy in children with acute lymphoblastic leukemia.
1/2019	Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
1/2018	Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group.
12/2017	A cost analysis of individualized asparaginase treatment in pediatric acute lymphoblastic leukemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rob Pieters Research Topics

Disease

121	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022 - 01/2002
44	Neoplasms (Cancer) 01/2022 - 04/2002
32	Leukemia 12/2022 - 01/2002
18	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019 - 09/2005
17	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2022 - 01/2006
13	Hypersensitivity (Allergy) 01/2022 - 01/2011
10	Neuroblastoma 01/2022 - 04/2002
10	Residual Neoplasm 01/2022 - 12/2008
9	Brain Neoplasms (Brain Tumor) 07/2013 - 08/2003
8	Glucocorticoid Receptor Deficiency 06/2015 - 08/2005
7	Osteonecrosis (Kienbock's Disease) 01/2021 - 10/2008
6	Wilms Tumor (Wilm's Tumor) 01/2013 - 03/2006
5	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 08/2006
5	Philadelphia Chromosome 12/2018 - 11/2010
5	Mucositis 08/2007 - 06/2006
4	Thrombosis (Thrombus) 01/2020 - 03/2006
4	Stomatitis 10/2018 - 08/2007
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 01/2012
4	Infections 03/2015 - 04/2012
4	Pathologic Complete Response 04/2011 - 07/2007
4	Ependymoma 12/2008 - 06/2007
3	Hypertriglyceridemia 01/2020 - 02/2012
3	Insulin Resistance 01/2016 - 05/2012
3	Down Syndrome (Down's Syndrome) 07/2015 - 01/2002
3	Carcinoma (Carcinomatosis) 05/2014 - 04/2004
3	Primitive Neuroectodermal Tumors (PNET) 10/2013 - 04/2002
3	Medulloblastoma 12/2008 - 08/2008
2	Pancreatitis 01/2020 - 11/2014
2	Obesity 01/2020 - 01/2012
2	Myeloid Leukemia (Leukemia, Myelocytic) 07/2015 - 04/2013
2	Hematologic Neoplasms (Hematological Malignancy) 10/2013 - 10/2010
2	Diarrhea 07/2013 - 08/2007

Drug/Important Bio-Agent (IBA)

34	Asparaginase (Elspar)FDA Link 01/2022 - 04/2003
24	Pharmaceutical PreparationsIBA 01/2022 - 01/2002
18	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2003
15	Prednisolone (Predate)FDA LinkGeneric 11/2019 - 08/2004
14	Methotrexate (Mexate)FDA LinkGeneric 12/2019 - 07/2005
12	GlucocorticoidsIBA 06/2022 - 08/2005
12	Dexamethasone (Maxidex)FDA LinkGeneric 04/2022 - 01/2006
8	Messenger RNA (mRNA)IBA 10/2011 - 02/2003
7	SteroidsIBA 06/2022 - 09/2012
7	Vincristine (Oncovin)FDA LinkGeneric 11/2019 - 08/2004
7	Biological ProductsIBA 01/2019 - 05/2007
7	MicroRNAs (MicroRNA)IBA 05/2017 - 10/2010
7	Biomarkers (Surrogate Marker)IBA 12/2016 - 06/2007
6	Prednisone (Sone)FDA LinkGeneric 01/2022 - 12/2007
6	AntibodiesIBA 01/2022 - 01/2011
6	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2021 - 08/2005
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 07/2009
5	Imatinib Mesylate (Gleevec)FDA Link 12/2018 - 09/2012
4	inhibin BIBA 11/2016 - 10/2007
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2006 - 04/2002
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2022 - 11/2012
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 01/2014
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021 - 12/2016
3	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2021 - 08/2004
3	AsparagineIBA 01/2020 - 12/2008
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019 - 07/2005
3	EnzymesIBA 01/2018 - 02/2003
3	multidrug resistance-associated protein 1IBA 05/2014 - 04/2004
3	AnticoagulantsIBA 03/2014 - 08/2008
3	Small Interfering RNA (siRNA)IBA 05/2013 - 05/2008
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2009 - 08/2007
3	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2007 - 02/2003
3	LigandsIBA 11/2003 - 04/2002
2	Chimeric Antigen ReceptorsIBA 12/2022 - 01/2022
2	fludarabineIBA 12/2022 - 01/2006
2	Indicators and Reagents (Reagents)IBA 04/2022 - 01/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 03/2014
2	Thymidylate SynthaseIBA 10/2018 - 07/2005
2	pegaspargase (Oncaspar)FDA Link 01/2018 - 04/2011
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 03/2014
2	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 05/2012
2	TensinsIBA 01/2016 - 07/2014
2	nuclear pore complex protein 98IBA 01/2016 - 09/2011
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016 - 07/2014
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2016 - 04/2015
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 08/2014 - 07/2013
2	Drug CombinationsIBA 10/2013 - 06/2007
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2013 - 09/2005
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2013 - 02/2003
2	Anaplastic Lymphoma KinaseIBA 03/2012 - 10/2011
2	Core Binding Factors (Core-Binding Factor)IBA 10/2011 - 03/2011
2	Oncogene Proteins (Oncogene Protein)IBA 05/2011 - 08/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2011 - 05/2007
2	Procarbazine (Matulane)FDA Link 06/2009 - 12/2007
2	Dacarbazine (DIC)FDA LinkGeneric 06/2009 - 12/2007
2	Vinblastine (Vinblastine Sulfate)FDA Link 06/2009 - 12/2007
2	Epirubicin (Ellence)FDA LinkGeneric 06/2009 - 12/2007
2	Bleomycin (Blenoxane)FDA LinkGeneric 06/2009 - 12/2007

Therapy/Procedure

41	Therapeutics 04/2022 - 09/2006
27	Drug Therapy (Chemotherapy) 01/2020 - 08/2004
9	Aftercare (After-Treatment) 11/2016 - 12/2007
7	Stem Cell Transplantation 01/2022 - 09/2012
6	Radiotherapy 03/2016 - 12/2007
6	Combination Drug Therapy (Combination Chemotherapy) 06/2009 - 04/2005
2	Immunotherapy 01/2022 - 11/2005
2	Palliative Care (Palliative Therapy) 01/2017 - 12/2016
2	Hematopoietic Stem Cell Transplantation 11/2010 - 10/2010
2	Drug Tapering 07/2010 - 03/2010